Xenetic Biosciences share price logo

Xenetic Biosciences

NASDAQ: XBIO

$2.24

as on

Xenetic Biosciences Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    $2.19
    $2.24
    downward going graph

    2.23%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.87
    $13.93
    downward going graph

    16.52%

    Downside

    521.87%

    Upside

    downward going graph

Xenetic Biosciences share price movements today

Previous Close
$2.24
Open
$2.22
Volume
266.7K
Market Cap
$5.2M
Day's Low - High
$2.19 - $2.24
52 Week Low - High
$1.87 - $13.93

Xenetic Biosciences Historical Returns

1 Month Return
-51.62 %
3 Month Return
-19.13 %
1 Year Return
-31.29 %
3 Year Return
-48.27 %
5 Year Return
-89.23 %

Xenetic Biosciences Stock Fundamentals & Key Indicators

Check Xenetic Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.2M

EPS (TTM)

-1.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.92

Industry PE ratio

-2.27

PEG Ratio

-0.04

EBITDA

-2.5M

Revenue (TTM)

3.3M

Profit Margin

100.00%

Return On Equity TTM

-40.62%

Xenetic Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenetic Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Xenetic Biosciences image
Xenetic Biosciences
Hold$5.2M-89.23%-1.92100.00%0.00%
Revolution Medicines image
Revolution Medicines
StrongBuy$44.1B609.62%-23.340.00%0.00%
Moderna image
Moderna
Neutral$75.4B-44.29%-24.08-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.5B180.98%30.1986.04%0.00%
Regeneron image
Regeneron
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Xenetic Biosciences Stock including INR - Dollar returns

The Xenetic Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Xenetic Biosciences investment value today

Current value as on today

₹74,570

Returns

-₹25,430

(-25.43%)

Returns from Xenetic Biosciences Stock

-₹31,288 (-31.29%)

Dollar Impact

₹5,858 (+5.86%)

Analyst Recommendation on Xenetic Biosciences Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Xenetic Biosciences. Average target price of $40

Xenetic Biosciences Share Price Target

Get share price movements and forecasts by analysts on Xenetic Biosciences.

What analysts predicted

94.4%UPSIDE

Target Price

$40

Current Price

$2.24

Analyzed by

6 Analysts

Target

$40.00

Xenetic Biosciences target price $40, a slight upside of 94.4% compared to current price of $2.24. According to 6 analysts rating.

Indian Investors' Interest in Xenetic Biosciences Stock

Search interest for Xenetic Biosciences Stock has increased by 106% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:106% versus previous 30 day period

Xenetic Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
1
0
0
0
Gross Profit
0
0
0
0
0
0
1
0
0
0
Operating Income
-1
-1
0
-1
0
0
0
0
0
0
EBITDA
-1
-1
0
-1
0
0
0
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
0
-1
0
0
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
0
-1
0
0
0
0
0
0
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Xenetic Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
-
0
0
1
1
2
2
2
Gross Profit
7
0
0
0
1
1
2
2
2
Operating Income
-3
-7
-12
-13
-5
-6
-4
-4
-2
EBITDA
-3
-7
-9
-4
-5
-6
-4
-3
-2
Interest Expense
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
-
0
-
Income Before Tax
-3
-7
-12
-13
-5
-6
-4
-3
-2
Income Tax Expense
0
0
-
-2
-
-
-
-
-
Net Income
-3
-7
-12
-10
-5
-6
-4
-3
-2
Net Profit Margin
97.94%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Xenetic Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
0
-1
0
0
0
0
0
0
Operating Cash Flow
-1
0
0
0
-1
0
0
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
4
-
-
Change in Cash
-1
0
0
0
-1
0
0
3
0
0

Xenetic Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-7
-12
-10
-5
-6
-4
-3
-2
Operating Cash Flow
1
-6
-6
-4
-4
-4
-4
-2
-2
Investing Cash Flow
0
0
0
-
-
0
-
-
-
Financing Cash Flow
0
1
16
5
11
-
-
-
4
Change in Cash
1
-4
9
1
6
-5
-4
-2
1

Global Institutional Holdings in Xenetic Biosciences

Check out the Institutions with significant holdings in Xenetic Biosciences.

Funds
Holdings
Fidelity Concord Street Trust
0.56%
Vanguard
0.54%
VANGUARD INDEX FUNDS
0.29%

Xenetic Biosciences News & Key Events

  • img

    Today's Timeline - 16 September

    Wed, 04:40 PM

    -

    Xenetic Biosciences to acquire Santersus in all-stock transaction, creating Santersus Bio, pending stockholder approval.

Insights on Xenetic Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 598.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 130.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -456.38K → -929.69K (in $), with an average decrease of 103.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, XBIO stock has moved down by -52.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 806.92K → 660.60K (in $), with an average decrease of 18.1% per quarter

About Xenetic Biosciences

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is specifically engineered to identify and attack distinct tumor neoantigens found in individual patients. Beyond this specialized area, the company actively engages in the discovery, investigation, and creation of advanced biologic medicines and cancer treatments. A significant part of its cell-based therapeutic endeavors involves therapies designed to target the B-cell receptor on the exterior of malignant tumor cells in specific patients, with the aim of addressing B-cell lymphomas. Furthermore, Xenetic capitalizes on its proprietary drug delivery technology, PolyXen, through strategic alliances with various biotechnology and pharmaceutical enterprises. The company has established important collaborative agreements with partners including Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. has its headquarters located in Framingham, Massachusetts.
OrganisationXenetic Biosciences
Headquarters945 Concord Street, Framingham, MA, 01701, US
IndustryBiotechnology
CEOJames F. Parslow

Key Management of Xenetic Biosciences

Name

Title

Mr. James F. Parslow

CFO, COO, Interim CEO & Corporate Secretary

FAQs

What is Xenetic Biosciences share price today?

Xenetic Biosciences share price today is $2.24 as on at the close of the market. Xenetic Biosciences share today touched a day high of $2.24 and a low of $2.19.

What is the 52 week high and 52 week low for Xenetic Biosciences share?

Xenetic Biosciences share touched a 52 week high of $13.93 on and a 52 week low of $1.87 on . Xenetic Biosciences stock price today i.e. is closed at $2.24,which is 83.92% down from its 52 week high and 19.79% up from its 52 week low.

What is Xenetic Biosciences's market capitalisation today?

Xenetic Biosciences market capitalisation is $0.00T as on .

How to invest in Xenetic Biosciences Stock (XBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenetic Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Xenetic Biosciences Stock (XBIO) from India?

Indian investors can start investing in Xenetic Biosciences (XBIO) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Xenetic Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Xenetic Biosciences share’s latest price of $2.24 as on October 3, 2026 at 8:46 am IST, you will get 4.4643 shares of Xenetic Biosciences. Learn more about fractional shares .

What are the returns that Xenetic Biosciences has given to Indian investors in the last 5 years?

Xenetic Biosciences stock has given -89.23% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?